Related Experiment Video
Updated: Jun 28, 2026

Injection of Porcine Adipose Tissue-Derived Stroma Cells via Waterjet Technology
Published on: November 23, 2021
Injection therapy: advancing the treatment of vesicoureteral reflux
Andrew Kirsch1, Terry Hensle, Hal Scherz
1Department of Pediatric Urology, Children's Healthcare of Atlanta, Emory University School of Medicine, 5445 Meridian Mark Road, Atlanta, GA 30342, USA. akirschmd@aol.com
Insights
Endoscopic injection using NASHA/Dx gel offers a safe and effective first-line treatment for pediatric vesicoureteral reflux (VUR), showing success rates comparable to surgery.
Area of Science:
- Pediatric Urology
- Minimally Invasive Surgery
Background:
- Vesicoureteral reflux (VUR) is a common congenital condition in children, often diagnosed after urinary tract infections.
- Current VUR treatments include observation, antibiotics, open surgery, and endoscopic injection.
Purpose of the Study:
- To review evidence and clinical experience regarding VUR treatment options.
- To evaluate endoscopic injection, specifically with NASHA/Dx gel, as a primary VUR treatment.
Main Methods:
- Literature review of VUR treatment evidence.
- Clinical experience with endoscopic injection (NASHA/Dx gel).
Main Results:
- Endoscopic injection with NASHA/Dx gel demonstrates an excellent safety profile.
- Success rates for NASHA/Dx gel injection approach those of open ureteral reimplantation.
- Endoscopic injection presents fewer disadvantages compared to open surgery or antibiotic prophylaxis.
Conclusions:
- Endoscopic injection, particularly with NASHA/Dx gel, is a highly recommended first-line treatment for VUR.
- A short course of antibiotics may precede endoscopic injection therapy.
- This minimally invasive approach offers a favorable alternative for managing pediatric VUR.
Abstract:
Vesicoureteral reflux (VUR) is a common urological anomaly among children, and is usually diagnosed following the occurrence of urinary tract infection(s). Treatment options are observation (non-treatment), antibiotic prophylaxis, ureteral reimplantation (open surgery) and endoscopic injection. The need for treatment of VUR is considered in light of the likelihood of spontaneous resolution and practical issues regarding management of the condition. The available evidence relating to the treatment options is reviewed alongside our experience in the clinic. Endoscopic injection, particularly when non-animal stabilized hyaluronic acid/dextranomer (NASHA/Dx) gel is used, has an excellent safety profile and fewer disadvantages than either open surgery or antibiotic prophylaxis. Post-treatment success rates approaching those with open surgery have been reported with NASHA/Dx gel. We conclude that endoscopic injection may be routinely recommended as a first-line treatment for VUR following a short period of antibiotic treatment.
Related Concept Videos
Imaging Studies V: Intravenous Urography and Retrograde Pyelography
Imaging Studies VI: Voiding Cystourethrography and Cystography
Urinary Tract Calculi III: Medical Management
Urinary Tract Infection IV: Nursing Management
Urinary Tract Calculi VI: Surgical Management
Kidney Transplant II: Surgical Procedure